Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07243067 · ClinicalTrials.gov registry record
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 300
- Enrollment target
NCT07243067: Clinical Trial study, sponsored by Mayo Clinic.
NCT07243067 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07243067 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 300 participants
- Enrollment target
Study Summary
This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively collect blood specimens pre and post nephrectomy.
Interventions
- PROCEDURE Blood sample collection
- OTHER Proteomic profiling of urinary EVs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07243067
The ClinicalTrials.gov registry entry for NCT07243067 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sample collection is the first listed.
NCT07243067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07243067 about?
NCT07243067 is a clinical study titled "Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer". This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively...
What is the current status of trial NCT07243067?
This trial is currently not yet recruiting. The enrollment target is 300 participants. The study started on 2026-07-15. Estimated completion is 2027-04-30.
What interventions are being tested in trial NCT07243067?
The interventions under investigation include: Blood sample collection (PROCEDURE), Proteomic profiling of urinary EVs (OTHER).
Who is sponsoring clinical trial NCT07243067?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.